Cargando…
Cognitive impairment and elevated peripheral cytokines in breast cancer patients receiving chemotherapy
BACKGROUND: Anthracyclines-based regimen (5-fluorouracil, doxorubicin, and cyclophosphamide (FAC); cyclophosphamide, epirubicin, and 5-fluorouracil [CEF]) and non-anthracycline based regimens (cyclophosphamide, methotrexate, and 5-fluorouracil [CMF]) are widely used as neoadjuvant chemotherapy for b...
Autores principales: | Khan, Mohd Ashif, Bhurani, Dinesh, Hoda, Ubedul, Sehar, Nouroz, Agarwal, Nidhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academia Brasileira de Neurologia - ABNEURO
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9703892/ https://www.ncbi.nlm.nih.gov/pubmed/36252586 http://dx.doi.org/10.1055/s-0042-1755234 |
Ejemplares similares
-
Association of diabetes and hypertension with disease severity in covid-19 patients: A systematic literature review and exploratory meta-analysis
por: Parveen, Rizwana, et al.
Publicado: (2020) -
Aldehyde dehydrogenase 2 polymorphism is associated with chemotherapy‐related cognitive impairment in patients with breast cancer who receive chemotherapy
por: Yao, Senbang, et al.
Publicado: (2022) -
Editorial: Cognitive Impairment and Peripheral Neuropathy From Chemotherapy: Molecular Mechanisms and Therapeutic Approaches
por: Milutinovic, Bojana, et al.
Publicado: (2022) -
Inhibition of dual leucine zipper kinase prevents chemotherapy-induced peripheral neuropathy and cognitive impairments
por: Ma, Jiacheng, et al.
Publicado: (2021) -
Risk factors for chemotherapy‐induced peripheral neuropathy in patients receiving taxane‐ and platinum‐based chemotherapy
por: Molassiotis, Alex, et al.
Publicado: (2019)